ARK Genomic Revolution ETF Rating → Urgent dollar warning (From Stansberry Research) (Ad) Free ARKG Stock Alerts $23.97 +0.68 (+2.92%) (As of 05/1/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings ARK Genomic Revolution ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.ARKG Aggregate RatingModerate Buy2.63Holdings in ARKG have an aggregate rating of Moderate Buy based on 386 analyst ratings issued in the past year covering 38 companies (99.3% of the portfolio).ARKG Aggregate Price Target$44.7486.67% UpsideHigh Prediction$65.23Average Prediction$44.74Low Prediction$26.92Holdings in ARKG have an aggregate price target of $44.74 and a range of $26.92 to $65.23 covering 38 companies (99.3% of the portfolio).ARKG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy10 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ARK Genomic Revolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 38 ARKG Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.04%CRSPCRISPR Therapeutics$54.26+0.8%3 of 5 stars2.38$76.29 40.6%166.78%TWSTTwist Bioscience$31.09-2.7%3 of 5 stars3.00$36.40 17.1%4Gap Up5.49%RXRXRecursion Pharmaceuticals$8.47+1.6%3 of 5 stars2.40$12.75 50.5%5Gap Up5.27%EXASExact Sciences$59.60-0.7%4 of 5 stars2.86$97.44 63.5%14Upcoming EarningsPositive News4.69%SDGRSchrödinger$23.15-8.4%3 of 5 stars2.67$43.50 87.9%9News Coverage4.41%IONSIonis Pharmaceuticals$42.93-0.2%4 of 5 stars2.69$56.08 30.6%13Upcoming EarningsPositive News3.93%NTLAIntellia Therapeutics$22.41-0.4%4 of 5 stars2.69$67.00 199.0%13Gap Down3.81%TXG10x Genomics$25.96-3.6%4 of 5 stars2.58$48.50 86.8%12Earnings ReportAnalyst ReportNews CoverageGap Down3.60%DNAGinkgo Bioworks$0.85+0.9%1 of 5 stars2.00$2.20 158.9%5Upcoming EarningsOptions Volume3.48%BEAMBeam Therapeutics$22.35+2.8%2 of 5 stars2.38$41.00 83.4%13Upcoming EarningsNews CoverageGap Down3.47%CDNACareDx$9.20+0.2%4 of 5 stars2.60$14.00 52.2%5Upcoming EarningsAnalyst UpgradeShort Interest ↓News CoveragePositive NewsGap Up3.44%ARCTArcturus Therapeutics$26.81-3.9%2 of 5 stars3.00$61.33 128.8%7Upcoming EarningsNews Coverage3.31%TDOCTeladoc Health$12.74-0.5%3 of 5 stars2.35$18.73 47.0%17Earnings ReportAnalyst ReportAnalyst Revision3.29%MRNAModerna$119.62+7.3%4 of 5 stars2.25$126.49 5.7%16Gap Up3.27%ACCDAccolade$7.31-0.7%5 of 5 stars2.75$14.57 99.3%16Earnings ReportAnalyst ReportAnalyst Revision2.94%VCYTVeracyte$19.83-1.5%4 of 5 stars2.60$29.00 46.2%5Upcoming Earnings2.83%VEEVVeeva Systems$199.79+0.4%5 of 5 stars2.65$234.90 17.6%20Positive News2.66%VRTXVertex Pharmaceuticals$400.07-0.5%4 of 5 stars2.48$429.45 7.3%23Upcoming Earnings2.47%LABStandard BioTools$2.52-0.8%3 of 5 stars3.00$3.58 42.2%3Upcoming Earnings2.42%NRIXNurix Therapeutics$12.90-1.4%2 of 5 stars2.83$21.33 65.4%6Gap Up2.11%ADPTAdaptive Biotechnologies$2.81+0.7%4 of 5 stars2.67$6.80 142.0%6Upcoming Earnings1.76%MASS908 Devices$5.57-1.9%2 of 5 stars3.00$14.00 151.3%1Earnings ReportAnalyst RevisionNews CoverageGap Up1.63%INCYIncyte$52.67-0.5%5 of 5 stars2.47$74.93 42.3%17Analyst Report1.57%QSIQuantum-Si$1.75-3.1%2 of 5 stars2.33$2.67 52.8%3Upcoming EarningsNews Coverage1.53%PACBPacific Biosciences of California$1.74+2.7%3 of 5 stars2.53$7.77 348.0%15Upcoming Earnings1.41%CMPSCOMPASS Pathways$8.33-1.8%1 of 5 stars3.00$47.40 469.0%5Upcoming EarningsAnalyst ReportShort Interest ↑News Coverage1.39%VERVVerve Therapeutics$6.04+0.7%2 of 5 stars2.75$33.00 446.4%8Gap Down1.21%REGNRegeneron Pharmaceuticals$916.37+1.4%4 of 5 stars2.70$977.77 6.7%20Analyst DowngradeInsider Selling1.19%ABSIAbsci$5.06-2.5%3 of 5 stars3.00$9.25 82.8%4Positive News1.14%PRMEPrime Medicine$5.13-2.7%3 of 5 stars2.70$16.89 229.2%10Upcoming Earnings1.12%PATHUiPath$19.08-0.8%4 of 5 stars2.50$27.41 43.7%181.08%AMGNAmgen$276.91-0.2%5 of 5 stars2.53$297.40 7.4%191.05%CERSCerus$1.71-0.6%2 of 5 stars2.67$3.50 104.7%30.73%PSNLPersonalis$1.58+1.9%4 of 5 stars3.00$5.00 216.5%3Upcoming EarningsAnalyst ReportNews Coverage0.64%RPTXRepare Therapeutics$3.42+3.6%3 of 5 stars3.00$17.33 406.8%40.59%NTRANatera$92.99-1.2%2 of 5 stars3.00$86.40 -7.1%14Analyst UpgradeInsider Selling0.50%GHGuardant Health$18.24-0.1%4 of 5 stars2.85$37.91 107.8%13Upcoming EarningsAnalyst Report0.04%SNTISenti Biosciences$0.383 of 5 stars3.00$6.00 1,478.9%1Gap Up This page (BATS:ARKG) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportUrgent dollar warningStansberry ResearchYour bank is lying to you.MyBankTrackerDollar CancelledLear Capital Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
